Upadacitinib Impurity 78 | CAS 433-06-7 - Request Quote
Upadacitinib Impurity 78
| SZ CAT No: | SZ-U005089 |
| CAS No | 433-06-7 |
| Mol.F. | C9H9F3O3S |
| Mol.Wt. | 254.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Upadacitinib Impurity 78 is chemically 2,2,2-Trifluoroethyl 4-methylbenzenesulfonate. Upadacitinib Impurity 78 is supplied with detailed characterization data compliant with regulatory guideline. Upadacitinib Impurity 78 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Upadacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 433-06-7
Purchase 433-06-7
Order 433-06-7
Enquire 433-06-7
price of 433-06-7
433-06-7 Supplier
433-06-7 Manufacturer
433-06-7 Exporter
buy high quality Upadacitinib Impurity 78
Purchase Upadacitinib Impurity 78
Upadacitinib Impurity 78 suppliers
Upadacitinib Impurity 78 manufacturers
Upadacitinib Impurity 78 price
Order Upadacitinib Impurity 78
Enquire Upadacitinib Impurity 78
Upadacitinib Impurity 78 cost
Upadacitinib Impurity 78 Supplier
Upadacitinib Impurity 78 Distributor
Upadacitinib Impurity 78 for Method Validation
Upadacitinib Reference Standard
Upadacitinib Impurity 78 for ANDA Filing
Upadacitinib Impurity 78 for Forced Degradation Studies
Upadacitinib Impurity 78 Identification Standards
Upadacitinib Impurity 78 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


